胆固醇酯贮积病中的严重慢性腹泻和体重减轻：一例报告
Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report.
作者信息
Drebber Uta, Andersen Matthias, Kasper Hans U, Lohse Peter, Stolte Manfred, Dienes Hans P
机构信息
Institute of Pathology, University of Cologne, Joseph-Stelzmann-Strasse 9, D-59031 Cologne, Germany.
出版信息
World J Gastroenterol. 2005 Apr 21;11(15):2364-6. doi: 10.3748/wjg.v11.i15.2364.
Abstract
AIM
An inherited deficiency of human lysosomal acid lipase (LAL) results in the rare conditions of Wolman disease and cholesteryl ester storage disease (CESD). We want to present the rare case of CESD in an adult.
METHODS
We report about an adult female patient with severe chronic diarrhea and weight loss as a consequence of CESD. Clinical examination revealed signs of malabsorption and slightly elevated liver enzymes.
RESULTS
Histopathologic changes in the liver tissue and DNA sequence analysis confirmed the diagnosis of CESD due to homozygosity for the most common CESD mutation, a G934A splice site defect encoded by exon 8 of the lysosomal acid lipase (LIPA) gene.
CONCLUSION
It is the first case in the literature with diarrhea as a putative symptom of CESD in adult patients.
摘要
目的
人类溶酶体酸性脂肪酶（LAL）的遗传性缺乏会导致罕见的沃尔曼病和胆固醇酯贮积病（CESD）。我们想要呈现一例成年患者患CESD的罕见病例。
方法
我们报告了一名成年女性患者，因CESD出现严重慢性腹泻和体重减轻。临床检查发现吸收不良体征及肝酶轻度升高。
结果
肝组织的组织病理学改变和DNA序列分析证实了CESD的诊断，原因是溶酶体酸性脂肪酶（LIPA）基因第8外显子编码的最常见CESD突变G934A剪接位点缺陷的纯合性。
结论
这是文献中首例将腹泻作为成年CESD患者推测症状的病例。
相似文献
1
Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report.
World J Gastroenterol. 2005 Apr 21;11(15):2364-6. doi: 10.3748/wjg.v11.i15.2364.
2
Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):99-106.
3
Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Protein Expr Purif. 2015 Jun;110:22-9. doi: 10.1016/j.pep.2014.12.009. Epub 2015 Jan 22.
4
Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
Mol Genet Metab. 2012 Mar;105(3):450-6. doi: 10.1016/j.ymgme.2011.12.008. Epub 2011 Dec 17.
5
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162.
6
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
J Hepatol. 2013 Sep;59(3):543-9. doi: 10.1016/j.jhep.2013.04.016. Epub 2013 Apr 25.
7
Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:125-32.
8
Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):682-5. doi: 10.1097/MPG.0b013e31828b36ac.
9
Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
Am J Cardiovasc Drugs. 2017 Jun;17(3):217-231. doi: 10.1007/s40256-017-0216-5.
10
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Gene. 2014 Apr 10;539(1):154-6. doi: 10.1016/j.gene.2014.02.003. Epub 2014 Feb 6.
引用本文的文献
1
The Hidden Burden: Gastrointestinal Involvement in Lysosomal Storage Disorders.
Metabolites. 2025 May 29;15(6):361. doi: 10.3390/metabo15060361.
2
Salvia officinalis flowers extract ameliorates liver and kidney injuries induced by simultaneous intoxication with ethanol/castor oil.
Physiol Rep. 2023 Nov;11(21):e15854. doi: 10.14814/phy2.15854.
3
Lysosomal Acid Lipase Deficiency, a Rare Pathology: The First Pediatric Patient Reported in Colombia.
Am J Case Rep. 2018 Jun 9;19:669-672. doi: 10.12659/AJCR.908808.
4
[Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease].
Pathologe. 2018 May;39(3):249-254. doi: 10.1007/s00292-017-0400-z.
5
Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.
Curr Chem Genom Transl Med. 2017 Jan 30;11:1-18. doi: 10.2174/2213988501711010001. eCollection 2017.
6
A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.
Eur Rev Med Pharmacol Sci. 2015;19(14):2628-2633.
7
Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.
Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G836-47. doi: 10.1152/ajpgi.00243.2014. Epub 2014 Aug 21.
8
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.
Hepatology. 2013 Sep;58(3):958-65. doi: 10.1002/hep.26327. Epub 2013 Jul 29.
9
Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.
Dig Dis Sci. 2009 Jan;54(1):168-73. doi: 10.1007/s10620-008-0310-2. Epub 2008 May 14.
本文引用的文献
1
Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease.
Int J Clin Pharmacol Ther. 2001 May;39(5):199-204. doi: 10.5414/cpp39199.
2
Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer.
J Hepatol. 2000 Mar;32(3):528-34. doi: 10.1016/s0168-8278(00)80407-9.
3
Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma.
Virchows Arch. 2000 Jan;436(1):82-7. doi: 10.1007/pl00008203.
4
Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.
J Lipid Res. 2000 Jan;41(1):23-31.
5
Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
Mol Genet Metab. 1999 Nov;68(3):333-45. doi: 10.1006/mgme.1999.2904.
6
Cholesteryl ester storage disease: case report during childhood.
Pediatr Dev Pathol. 1999 Nov-Dec;2(6):574-6. doi: 10.1007/s100249900164.
7
Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
J Lipid Res. 1999 Feb;40(2):221-8.
8
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
J Lipid Res. 1998 Jul;39(7):1382-8.
9
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin.
J Hepatol. 1997 Oct;27(4):744-50. doi: 10.1016/s0168-8278(97)80092-x.
10
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162.
Zotero 插件